_6-consejos-para-prevenir-la-diabetes-tipo-2-124-medif-124-shorts-preview-1.jpg "6 consejos para prevenir la diabetes tipo 2 | Medifé | #Shorts from fisterra diabetes tipo 2 Video Screenshot Preview 1")
Gallery_6-consejos-para-prevenir-la-diabetes-tipo-2-124-medif-124-shorts-preview-3.jpg "6 consejos para prevenir la diabetes tipo 2 | Medifé | #Shorts from fisterra diabetes tipo 2 Video Screenshot Preview 3")
Gallery_6-consejos-para-prevenir-la-diabetes-tipo-2-124-medif-124-shorts-preview-hqdefault.jpg "6 consejos para prevenir la diabetes tipo 2 | Medifé | #Shorts from fisterra diabetes tipo 2 Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 31 seconds
👁 View: 503 times
Play Audio:👁 View: 503 times
Description:
Medifé
Medifé
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_factores-de-riesgo-para-desarrollar-diabetes-tipo-2-marcoantonioregiltv-mrdoctor-shorts.webp "Mr Doctor")
⏲ 47 seconds 👁 26.4K
_descubre-la-verdad-sobre-el-arroz-blanco-y-la-diabetes-tipo-2.webp "Hacia un Nuevo Estilo de Vida")
_what-is-type-3-diabetes.webp "While most of us are familiar with type 1 and type 2 diabetes, you may not have come across the term ‘type 3 diabetes’ before.")
_todo-lo-que-necesitas-saber-de-la-diabetes-mellitus-glucosa-alta.webp "Dr. Alberto Sanagustín")
_11-causes-and-solution-of-belly-fat-accumulation.webp "11 Causes and Solution of Belly Fat Accumulation. <br/>Belly fat isn’t just a cosmetic concern; it poses significant health risks, wrapping around vital organs and increasing the likelihood of heart disease, diabetes, and cancer. To assess excess fat in this area, measure your midsection at belly button level. Women should aim for under 35 inches, while men should target below 40 inches. But fear not! By identifying the root causes and implementing targeted strategies, you can reclaim control over your waistline and overall well-being.<br/><br/>References:<br/>https://www.webmd.com/obesity/ss/slideshow-fasting-overview <br/>")
_4-consejos-para-prevenir-la-diabetes-124-clnica-alemana.webp "Clínica Alemana")
_no-ignores-estas-seales-que-son-sntomas-de-diabetes-tipo-2-124dr-william-guerrero-medicina-shorts.webp "DR. WILLIAM GUERRERO")
No ignores estas señales que son síntomas de diabetes tipo 2 |Dr. William Guerrero #medicina #shorts
⏲ 1 minute 👁 15K
_new-analysis-suggests-long-term-effectiveness-for-wegovy-users.webp "New Analysis Suggests , Long-Term Effectiveness , for Wegovy Users .<br/>NBC reports that patients taking <br/>Novo Nordisk's obesity treatment maintain <br/>an average of 10% weight loss over four years.<br/>The news potentially boosts the <br/>drugmaker's push for Wegovy to be <br/>covered by insurers and governments. .<br/>The company submitted long-term <br/>findings at the European Congress <br/>on Obesity in Venice, Italy. .<br/>This is the longest study <br/>we’ve conducted so far of <br/>semaglutide for weight loss, Martin Holst Lange, Novo’s head of development, via NBC.<br/>We see that once the majority <br/>of the weight loss is accrued, <br/>you don’t go back and start <br/>to increase in weight<br/>if you stay on the drug, Martin Holst Lange, Novo’s head of development, via NBC.<br/>According to another analysis published by <br/>the drugmaker, approximately 17% of trial participants stopped using the treatment <br/>due to side effects like nausea. .<br/>The costly treatment ranges from $200 <br/>to nearly $2,000 per month in the ten <br/>countries where the drug is available.<br/>NBC reports that Novo Nordisk was the <br/>first drugmaker to market GLP-1 agonists, <br/>originally developed as a diabetes treatment, <br/>to address record high obesity rates.<br/>NBC reports that Novo Nordisk was the <br/>first drugmaker to market GLP-1 agonists, <br/>originally developed as a diabetes treatment, <br/>to address record high obesity rates.<br/>Rival Eli Lilly launched its drug <br/>Zepbound in the United States <br/>in December of 2023. .<br/>Neither drugmaker has managed <br/>to produce enough of the <br/>treatment to meet surging demand")
_factores-de-riesgo-para-desarrollar-diabetes-tipo-2-marcoantonioregiltv-mrdoctor-shorts.jpg)
_descubre-la-verdad-sobre-el-arroz-blanco-y-la-diabetes-tipo-2.jpg)
_what-is-type-3-diabetes.jpg)
_todo-lo-que-necesitas-saber-de-la-diabetes-mellitus-glucosa-alta.jpg)
_11-causes-and-solution-of-belly-fat-accumulation.jpg)
_4-consejos-para-prevenir-la-diabetes-124-clnica-alemana.jpg)
_no-ignores-estas-seales-que-son-sntomas-de-diabetes-tipo-2-124dr-william-guerrero-medicina-shorts.jpg)
_new-analysis-suggests-long-term-effectiveness-for-wegovy-users.jpg)
![[+]](/images/menu.gif){kind=small}